2 completed, 1 terminated. 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 2, Terminated 1 |
Follow TAK-954: new trials by email Literature Review of TAK-954 trials Research Report on TAK-954
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of TAK-954 to Treat Gastrointestinal Dysfunction in Adults After Surgery TAK-954 Placebo, TAK-954 - Postoperative Gastrointestinal Dysfunction | Phase 2 | Completed | Takeda | 209 | 2019-03-07 | 2023-06-23 |
| TAK-954 in Critically Ill Participants With Enteral Feeding Intolerance (EFI) TAK-954, Metoclopramide, Normal Saline - Critical Illness, Enteral Nutrition | Phase 2 | Terminated | Millennium Pharmaceuticals, Inc. | 1 | 2018-08-25 | 2019-09-24 |
| Effect of TAK-954 on Gastrointestinal and Colonic Transit in Diabetic or Idiopathic Gastroparesis Participants TAK-954, Placebo - Diabetic Gastroparesis, Idiopathic Gastroparesis | Phase 2 | Completed | Takeda | 36 | 2018-01-02 | 2021-01-07 |
Critical Illness (1)
Takeda (2) · Millennium Pharmaceuticals, Inc. (1)
United States (3) · Australia (1) · Canada (1) · Germany (1) · United Kingdom (1)
2017 (1), 2018 (1)